The Motley Fool

2 small-cap stocks that could be millionaire-makers in 2018

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Happy retired couple on a yacht
Image source: Getty Images.

For many investors, finding stocks with upside potential is tough, even in the most genteel of market conditions. However, with share prices continuing to push higher, and the FTSE 100 making record high after record high, it may seem more challenging than ever to find the right investment opportunities. After all, no investor wants to buy any asset at a price which is too high.

With that in mind, here are two smaller companies which could realistically offer high returns in the long run. Both released updates on Monday and could be set to deliver rising share prices in future.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

Improving performance

Scientific instrument specialist Judges Scientific (LSE: JDG) released a positive trading update for the 2017 financial year. It has seen strong demand for its products in the second half, with organic order intake increasing by 16% versus the prior year. This means that the company enters 2018 with a robust order book that totals almost 15 weeks of sales compared to almost 14 weeks at the same time last year.

Encouragingly, the two businesses within the group that had experienced lower demand in 2016 recovered to normal levels of orders, sales and profitability. The business, which had been affected by production and supply chain problems, has made progress, while wider group sales and profits were driven by a healthy order intake and favourable exchange rates. As such, it is anticipated that earnings for 2017 will be ahead of expectations.

Due to its positive update, the Judges Scientific share price increased by 6% on Monday. However, it continues to trade on a price-to-earnings growth (PEG) ratio of just 1.3. This suggests that it could offer upside potential from its current price level and may be worth buying for the long term.

Growth potential

Also reporting on Monday was aesthetics company Sinclair Pharma (LSE: SPH). It announced a trading update for 2017 which showed that sales increased from £37.8m in 2016 to £45.3m. This represented headline growth of 20%, with sales up 25% between H2 and H1. A modest EBITDA (earnings before interest, tax, depreciation and amortisation) is expected for the year as a while.

The restructuring of its European operations started to bear fruit during the year. Growth potential in Korea and in the Middle East also remains high in the long run, while the company remains upbeat about its potential to increase sales in the next 12 months.

With Sinclair Pharma forecast to return to a black bottom line in 2018, and then deliver 290% profit growth in 2019, now could be an opportune moment to buy it. The company appears to have a sound strategy which could provide solid growth for a number of years. Having a forward price-to-earnings (P/E) ratio of 9.5 using 2019’s forecast earnings figure, it appears to offer a wide margin of safety.

5 Stocks For Trying To Build Wealth After 50

Markets around the world are reeling from the coronavirus pandemic…

And with so many great companies trading at what look to be ‘discount-bin’ prices, now could be the time for savvy investors to snap up some potential bargains.

But whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be daunting prospect during such unprecedented times.

Fortunately, The Motley Fool is here to help: our UK Chief Investment Officer and his analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global lock-down…

You see, here at The Motley Fool we don’t believe “over-trading” is the right path to financial freedom in retirement; instead, we advocate buying and holding (for AT LEAST three to five years) 15 or more quality companies, with shareholder-focused management teams at the helm.

That’s why we’re sharing the names of all five of these companies in a special investing report that you can download today for FREE. If you’re 50 or over, we believe these stocks could be a great fit for any well-diversified portfolio, and that you can consider building a position in all five right away.

Click here to claim your free copy of this special investing report now!

Peter Stephens owns shares in Judges Scientific. The Motley Fool UK has recommended Judges Scientific. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.